Cost-Effectiveness Analysis of Interferon Beta-1b for the Treatment of Patients With a First Clinical Event Suggestive of Multiple Sclerosis

Autor: Caloyeras, John P., Zhang, Bin, Wang, Cheng, Eriksson, Marianne, Fredrikson, Sten, Beckmann, Karola, Knappertz, Volker, Pohl, Christoph, Hartung, Hans-Peter, Shah, Dhvani, Miller, Jeffrey D., Sandbrink, Rupert, Lanius, Vivian, Gondek, Kathleen, Russell, Mason W.
Zdroj: In Clinical Therapeutics May 2012 34(5):1132-1144
Databáze: ScienceDirect
Externí odkaz: